
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
2
First patient treated in dose-expansion portion of SpliceBio's phase 1/2 ASTRA clinical trial
3
Ollin Biosciences reports positive head-to-head phase 1b data for OLN324 vs faricimab
4
Glaucoma innovation: Eight themes to watch in 2026
5





































































